Erector spinae plane blocks for opioid-sparing multimodal pain management after pediatric cardiac surgery

Nathalie Roy1, M Fernanda Parra1, Morgan L Brown2

  • 1Department of Cardiac Surgery, Boston Children's Hospital, Boston, Mass; Department of Surgery, Harvard Medical School, Boston, Mass.

Insights

Bilateral continuous erector spinae plane blocks (B-ESpB) are safe for pediatric cardiac surgery patients, reducing opioid use within 48 hours. This regional anesthesia technique supports enhanced recovery protocols in children.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Regional Anesthesia

Background:

  • Peripheral regional anesthesia is explored for improving patient recovery.
  • Enhanced recovery after cardiac surgery (ERACS) programs aim to optimize surgical outcomes.
  • The efficacy of bilateral continuous erector spinae plane blocks (B-ESpB) in pediatric cardiac surgery remains under investigation.

Purpose of the Study:

  • To evaluate the effectiveness of B-ESpB for postoperative pain management in children undergoing cardiac surgery.
  • To assess the impact of B-ESpB on the recovery process within an ERACS program.
  • To determine the safety profile of B-ESpB in this pediatric population.

Main Methods:

  • Prospective enrollment of pediatric patients (2-17 years) in an ERACS program receiving B-ESpB post-cardiac surgery.
  • Continuous postoperative infusions via catheters were administered.
  • Retrospective matching of B-ESpB patients with control patients within the ERACS program for outcome comparison.

Main Results:

  • Forty B-ESpB patients were matched with 78 controls; no major complications from B-ESpB were observed.
  • B-ESpB patients received significantly fewer opioids at 24 and 48 hours postoperatively (p < 0.05).
  • No significant differences were found in early mobilization, length of stay, or overall complications between groups.

Conclusions:

  • Bilateral continuous erector spinae plane blocks are a safe analgesic technique for pediatric cardiac surgery.
  • B-ESpB, as part of a multimodal pain strategy in ERACS, provides effective pain control and reduces opioid requirements in the initial 48 hours.
  • This regional anesthesia approach contributes to successful enhanced recovery in pediatric cardiac surgical patients.
Abstract

Related Concept Videos

Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
624
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
430
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
289
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
417